Novel approaches for the management of coronary artery disease

Angelidis, George; Valotassiou, Varvara; Κollia, Panagoula; Skoularigis, John; Tsougos, Ioannis; Georgoulias, Panagiotis

doi:10.1007/s00059-019-04885-z

Cited by 1 publication

(2 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Cardiovascular diseases (CVD), in particular, coronary artery disease (CAD), are a common, socially significant pathology worldwide [1][2][3]. Various clinical manifestations of CAD are classified as acute coronary syndrome (ACS) or chronic coronary syndrome (CCS).…”

Section: Rationalementioning

confidence: 99%

See 1 more Smart Citation

Brain-Derived Neurotrophic Factor And Coronary Artery Disease

et al. 2022

View full text Add to dashboard Cite

Coronary artery disease (CAD) is defined as myocardial damage developing as a result of its organic and functional changes, and leading to impaired blood flow through the coronary arteries. An important pathogenetic component of CAD is atherosclerosis. Currently, key aspects of the molecular relationship between inflammation and atherosclerosis are being actively studied, the immunometabolic theory of atherosclerosis is being discussed, along with an involvement of perivascular adipose tissue in the pathogenesis of this pathology, due to its ability to respond to atherogenic stimuli via developing inflammatory reactions. Evidence has been accumulated that in patients with CAD, both in their blood and perivascular adipose tissue, the level of neurotrophic factors (in particular, brain-derived neurotrophic factor, BDNF) changes, which may be a promising area of research from the standpoint of studying this factor as a therapeutic target for atherosclerosis in CAD. Neurotrophic growth factors control the functioning of both immune and nervous systems, and the balance of energy metabolism and innervation of adipose tissue. They affect vascular homeostasis, and are also involved in causing and stopping inflammation. Currently, there are data on the role of BDNF in the pathogenesis of cardiovascular, neurodegenerative and metabolic diseases, and on the effect of polyunsaturated fatty acids and eicosanoids on the level of BDNF and, accordingly, the development and progression of coronary artery atherosclerosis. Our review summarizes published data (2019-2021) on the pathophysiological and pathogenetic mechanisms of the relationship between BDNF and CAD (atherosclerosis).

show abstract

Section: Rationalementioning

confidence: 99%

“…CAD is defined as a myocardial lesion resulting from organic (atherosclerosis) and functional (spasm and intravascular thrombosis) changes and leading to impaired blood flow in the coronary arteries [2,4]. The concept of CAD combines acute (unstable) and chronic (stable) conditions.…”

Section: Coronary Artery Disease and Atherosclerosismentioning

confidence: 99%